New perspectives on the cardioprotective phosphonate effect of the spin trap 5-(diethoxyphosphoryl)-5-methyl-1-pyrroline N-oxide: An hemodynamic and P-31 NMR study in rat hearts
E. Maurelli et al., New perspectives on the cardioprotective phosphonate effect of the spin trap 5-(diethoxyphosphoryl)-5-methyl-1-pyrroline N-oxide: An hemodynamic and P-31 NMR study in rat hearts, FREE RAD B, 27(1-2), 1999, pp. 34-41
The spin trap 5-(diethoxyphosphoryl)-5-methyl-1-pyrroline N-oxide (DEPMPO)
is an improved ESR probe to assess superoxide (O-2(.-)) formation in the po
stischemic heart. We recently found that DEPMPO pretreatment improves recov
ery of cardiac function with the concomitant inhibition of postischemic O-2
(.-) production. By perfusing diethyl methylphosphonate MeP(O)(OEt)(2) to i
schemic-reperfused isolated rat hearts, we provide hemodynamic evidence tha
t this preservation, which exerts during ischemia, is in fact specific to t
he phosphonate group. Using P-31 NMR on intact rat hearts, it was also foun
d that the "phosphonate effect" of DEPMPO is related to the preservation of
ATP levels during ischemia, when compared to 5,5-dimethyl-1-pyrroline N-ox
ide. This mechanism may be a means of reducing the potency of cardiac tissu
e to produce O-2(.-) during reperfusion. (C) 1999 Elsevier Science Inc.